Navigation Links
Sudden Cardiac Death Much More Likely to Strike Men
Date:11/15/2009

Males have triple the odds than women, study finds, and black men are especially prone

SUNDAY, Nov. 15 (HealthDay News) -- Men, especially black men, are at a relatively high risk of sudden cardiac death over their lifetime compared to women, a new study finds.

That lifetime risk in men aged 40 and over is one in eight, or 12.3 percent -- triple that of women, whose risk is one in 24, or just over 4 percent, the study found.

"Compare this with the lifetime risk for lung cancer, which is one in 12 for men and one in 16 for colon cancer, and one in 17 for both in women," said Dr. Donald Lloyd-Jones, lead author of the study presented Sunday at the annual meeting of the American Heart Association, in Orlando, Fla. "These are diseases we think heavily about the consequences and certainly screen people."

"Relatively high lifetime risk estimates for such a devastating disease hopefully have implications for people thinking about prevention efforts," added Lloyd-Jones, who is associate professor of medicine and preventive medicine at the Bluhm Cardiovascular Institute, Feinberg School of Medicine, Northwestern University in Chicago.

"These are startling figures," said Dr. Elliott Antman, spokesman for the American Heart Association (AHA), and professor of medicine at Harvard Medical School and director of the Coronary Care Unit at Brigham and Women's Hospital, both in Boston.

Traditionally, estimates have focused on a person's risk of sudden cardiac death over the next 10 years. These new numbers are the first lifetime estimates for sudden cardiac death, Lloyd- Jones said.

According to the American Heart Association, some 300,000 cardiac arrests -- when the heart suddenly loses function, often without prior diagnosis of heart disease -- occur each year in the United States.

The study authors looked at sudden cardiac death data on nearly 5,000 U.S. adults involved in three major heart studies, following them from age 40 through age 95.

African-American men had roughly twice the risk as white men at any given age, while black and white women had roughly the same risk all the way through.

The risk for sudden cardiac death actually went down for both genders as age went up, the research team noted. That's because "we've depleted some of those individuals who were going to have an event at younger age, but at [age] 80 many things are competing to kill us so at that point sudden death is less likely to be a cause of death," Lloyd-Jones said.

Having traditional risk factors for heart disease -- such as high blood pressure, high cholesterol, diabetes, lack of physical activity and smoking cigarettes -- also upped the risk of sudden cardiac death substantially, the study found.

"If you reach the age of 50 with all optimal risk factors, essentially no one went on to experience sudden death in their remaining life span, whereas those with two or more major risk factors had much higher rates comparatively," Lloyd-Jones said.

The good news is that the same treatment and prevention strategies already advocated for reducing the risk of heart disease should cover both bases.

"Lowering the risk of heart attack also lowers the risk of dying suddenly," Antman said. "It helps you."

Certain drugs can also help ease heart risks, but two studies released Sunday at the AHA meeting found that a promising anti-clotting medication in development, cangrelor, was no better than the standard blood thinner clopidogrel (Plavix) for patients undergoing angioplasty. The study was also published online Sunday in the New England Journal of Medicine.

The two phase III trials took place at more than 200 sites in 18 countries and involved over 14,000 patients. In the larger of the two studies, involving nearly 9,000 patients, researchers found no significant difference in terms of death, heart attack or the need to re-open a vessel when patients received cangrelor just prior to angioplasty/stenting, followed by post-angioplasty Plavix, versus using Plavix (pre- and post-angioplasty) alone.

More patients also experienced bleeding with cangrelor, said the researchers, from Duke University's Clinical Research Institute, and elsewhere.

More information

There's more on heart health at the U.S. National Heart, Lung and Blood Institute.



SOURCES: Elliott Antman, M.D., American Heart Association spokesman, professor of medicine, Harvard Medical School and director, Coronary Care Unit, Brigham and Women's Hospital, Boston; Nov. 15, 2009, press conference with Donald M. Lloyd-Jones, M.D., associate professor of medicine and preventive medicine, Bluhm Cardiovascular Institute, Feinberg School of Medicine, Northwestern University, Chicago; Nov. 15, 2009, news release, Duke Clinical Research Institute; Nov. 15, 2009, presentation, American Heart Association annual meeting, Orlando, Fla.


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association
2. Study Sheds Light on Origins of Sudden Cardiac Death
3. Sudden Cardiac Arrest Association Launches Austin and Lubbock Chapters
4. Sudden Cardiac Arrest Association Launches Iowa Affiliate
5. Sudden Cardiac Arrest Association Launches Its First Thirteen Local Chapters/Affiliates
6. Sudden Cardiac Arrest Association Launches Kansas City Chapter
7. Sudden Cardiac Arrest Association Launches Long Island and Queens Chapters
8. Sudden Cardiac Arrest Association Launches South Florida Chapter
9. Sudden Cardiac Arrest Association Launches Southwest Connecticut Chapter
10. Sudden Cardiac Arrest Association Launches Two Minnesota Affiliates
11. Boston Scientific Announces First European Implants of New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... WA (PRWEB) , ... February 17, 2017 , ... ... management organizations, has been named a finalist in the 8th Annual DecisionHealth Platinum ... America's healthcare delivery system. Qualis Health’s work is recognized across multiple award categories, ...
(Date:2/17/2017)... ... 17, 2017 , ... Program will serve more than 5,000 ... U.S. Soccer Foundation announced today that they have awarded nine grants to expand ... Foundation’s soccer mentoring program, teaches kids the fundamentals of soccer while striving to ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... operations executives and focusing on all facets of clinical trial planning and management. ... , patient engagement, and more. In addition, attendees stopping by Pharmica’s booth were ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer ... Molecular Medicine Tri-Conference February 20 – 22 in San Francisco. As part of ... anatomic and molecular pathology workflow solution, as well as its new precision medicine ...
(Date:2/17/2017)... ... ... Top neuroendocrine cancer doctors, nurses and specialists from around the world will ... in Beaver Creek, CO. It was announced today by Cindy Lovelace, executive director of ... hosting over 60 faculty members and addressing unmet needs of the NET community. ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... Feb. 16, 2017 Research and Markets ... Emerging Medical Device Technologies" report to their offering. ... Traditional ... procedures, general instruments, non-drug coated implantables, large endoscopes, needle based ... use over the last two to three decades for the ...
(Date:2/16/2017)... Ontario , Feb. 16, 2017  Aralez Pharmaceuticals ... global specialty pharmaceutical company, today announced that executive management ... Conference to be held February 22-23, 2017. Adrian ... of the Company at 1:35 p.m. local time on ... and audio archive for the event may be accessed ...
(Date:2/16/2017)... , Feb. 16, 2017  AcelRx Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that Vincent J. Angotti ... a member of the company,s board of directors, ... over two decades of experience leading executive and ...
Breaking Medicine Technology: